Sofinnova Investments, Inc.
•CIK: 1631134•Filing: Q4 2025
**Sofinnova Investments, Inc.** manages $2.3B across a concentrated portfolio of 60 positions. The fund exhibits significant conviction in the healthcare sector, with top holdings including NTRA at $355.2M and MRX at $163.2M. Further notable allocations include AZN ($150.1M) and VERA ($141.5M), signaling a deep focus on innovative biopharma and life sciences opportunities. This structure suggests a high-conviction, sector-specific mandate within the healthcare value chain.
Total AUM
$2.3B
QoQ Performance
+50.4%
Positions
60
Top 10 Concentration
54.2%
Latest Filing
Q4 2025
Top Holdings Allocation
NTRA
JAZZ
AZN
VERA
NTRA15.3%
JAZZ7.0%
AZN6.5%
VERA6.1%
BMY3.5%
UTH3.3%
VRTX3.2%
ABBV3.1%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other90.5%
Healthcare9.5%
🚪 Exited Positionssold since Q3 2025
+5 more exited positions
Changes from Q3 2025
NEW11 new positions
↑23 increased
↓18 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023